• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

XI因子缺乏家族中出血倾向的定义——一项临床与实验室研究

Definition of the bleeding tendency in factor XI-deficient kindreds--a clinical and laboratory study.

作者信息

Bolton-Maggs P H, Patterson D A, Wensley R T, Tuddenham E G

机构信息

Department of Haematology, Royal Liverpool University Hospital, UK.

出版信息

Thromb Haemost. 1995 Feb;73(2):194-202.

PMID:7792729
Abstract

Individuals with severe factor XI deficiency are prone to excessive bleeding after injury or surgery, but the existence of a haemorrhagic tendency in partial factor XI deficiency is controversial. In this study, 172 members of 30 kindreds (20 non-Jewish) transmitting factor XI deficiency in North West England were interviewed and a bleeding history questionnaire completed. Blood was taken for coagulation assays. The questionnaires were categorised independently by two assessors to determine presence or absence of a bleeding tendency, in the absence of information about the factor XI level or family history. Analysis shows that 48% of heterozygotes have a bleeding tendency. Eighteen (60%) families came to attention because of bleeding problems in heterozygotes. Comparison of histories between partially deficient and non-deficient individuals demonstrated a higher incidence of menstrual problems, an increase in significant bruising, and an increased likelihood of excessive bleeding after tonsillectomy and dental extractions. The incidence of von Willebrand's disease was not increased, but individuals with heterozygous factor XI deficiency who were bleeders tended to have lower levels of factor VIIIc and von Willebrand factor, and were more commonly of blood group 0. These features may contribute to the bleeding tendency. There was no evidence of alteration in factor VII activity (as defined by the ratio of activity to antigen) between the bleeders and non-bleeders. This is convincing evidence for abnormal bleeding in factor XI deficiency which is not confined to severely deficient patients.

摘要

患有严重因子XI缺乏症的个体在受伤或手术后容易出现过度出血,但部分因子XI缺乏症患者是否存在出血倾向仍存在争议。在本研究中,对英格兰西北部30个家族(20个非犹太家族)中172名携带因子XI缺乏症的成员进行了访谈,并完成了一份出血史问卷。采集血液进行凝血检测。在不了解因子XI水平或家族史的情况下,由两名评估人员独立对问卷进行分类,以确定是否存在出血倾向。分析表明,48%的杂合子有出血倾向。18个(60%)家族因杂合子的出血问题而受到关注。部分缺乏症患者与非缺乏症患者的病史比较显示,月经问题的发生率更高,明显瘀伤增多,扁桃体切除术后和拔牙后出血过多的可能性增加。血管性血友病的发病率没有增加,但有出血倾向的因子XI杂合子个体的因子VIIIc和血管性血友病因子水平往往较低,且血型多为O型。这些特征可能导致出血倾向。在出血者和非出血者之间,没有证据表明因子VII活性(以活性与抗原的比率定义)发生改变。这是因子XI缺乏症患者异常出血的有力证据,且这种出血倾向并不局限于严重缺乏症患者。

相似文献

1
Definition of the bleeding tendency in factor XI-deficient kindreds--a clinical and laboratory study.XI因子缺乏家族中出血倾向的定义——一项临床与实验室研究
Thromb Haemost. 1995 Feb;73(2):194-202.
2
The effect of combined factor XI deficiency with von Willebrand factor abnormalities on haemorrhagic diathesis.联合因子XI缺乏与血管性血友病因子异常对出血素质的影响。
Thromb Haemost. 1990 Feb 19;63(1):36-8.
3
[Hemophilia C, a deficiency of a contact phase protein which may involve a risk of hemorrhage].丙型血友病,一种接触相蛋白缺乏症,可能存在出血风险。
Schweiz Med Wochenschr. 1992 Mar 7;122(10):351-3.
4
Factor XI deficiency in Ashkenazi Jews in Israel.以色列阿什肯纳兹犹太人中的凝血因子XI缺乏症。
N Engl J Med. 1991 Jul 18;325(3):153-8. doi: 10.1056/NEJM199107183250303.
5
Simultaneous genotyping of coagulation factor XI type II and type III mutations by multiplex real-time polymerase chain reaction to determine their prevalence in healthy and factor XI-deficient Italians.通过多重实时聚合酶链反应同时对凝血因子XI II型和III型突变进行基因分型,以确定其在健康和凝血因子XI缺乏的意大利人中的患病率。
Haematologica. 2008 May;93(5):715-21. doi: 10.3324/haematol.12180. Epub 2008 Apr 2.
6
Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.隐性严重1型和3型血管性血友病(VWD)、无症状杂合子携带者与血型O相关的血管性血友病因子缺乏症以及显性1型VWD的特征分析
Clin Appl Thromb Hemost. 2006 Jul;12(3):277-95. doi: 10.1177/1076029606291401.
7
Differences between heterozygous dominant and recessive von Willebrand's disease type I expressed by bleeding symptoms and combinations of factor VIII variables.通过出血症状和因子VIII变量组合所表现出的杂合子显性和隐性I型血管性血友病之间的差异。
Thromb Haemost. 1983 Dec 30;50(4):864-8.
8
Definition of the population at risk of bleeding due to factor XI deficiency in Ashkenazic Jews and the value of activated partial thromboplastin time in its detection.阿什肯纳兹犹太人中因因子 XI 缺乏而有出血风险人群的定义及其检测中活化部分凝血活酶时间的价值。
Isr J Med Sci. 1981 Jun;17(6):413-5.
9
Co-existence of Bernard Soulier syndrome and factor XI deficiency in a family: a unified pathology?一个家族中伯纳德·索利尔综合征与因子XI缺乏症并存:一种统一的病理学?
Platelets. 2005 Mar;16(2):85-9. doi: 10.1080/09537100400010345.
10
[Prolonged activated partial thromboplastin time (aPTT): not always indicative of increased risk of bleeding].[活化部分凝血活酶时间(aPTT)延长:并不总是提示出血风险增加]
Ned Tijdschr Geneeskd. 2009;153:B42.

引用本文的文献

1
Design, synthesis, and biological evaluation of substituted oxopyridine derivatives as selective FXIa inhibitors.作为选择性因子XIa抑制剂的取代氧代吡啶衍生物的设计、合成及生物学评价
RSC Med Chem. 2025 May 28. doi: 10.1039/d4md01013b.
2
The factor XI/XIa antibody abelacimab combined with enoxaparin inhibits filter clotting in hemodialysis circuits ex vivo.XI因子/XIa因子抗体阿贝西单抗与依诺肝素联合使用可在体外抑制血液透析回路中的滤器凝血。
J Thromb Thrombolysis. 2024 Dec;57(8):1339-1348. doi: 10.1007/s11239-024-03059-x. Epub 2024 Nov 16.
3
Laboratory and Molecular Diagnosis of Factor XI Deficiency.
因子 XI 缺乏症的实验室及分子诊断
Semin Thromb Hemost. 2025 Mar;51(2):145-154. doi: 10.1055/s-0044-1792033. Epub 2024 Nov 4.
4
Targeting factor XI and factor XIa to prevent thrombosis.靶向因子 XI 和因子 XIa 以预防血栓形成。
Blood. 2024 Apr 11;143(15):1465-1475. doi: 10.1182/blood.2023020722.
5
Tissue factor pathway inhibitor is a potential modifier of bleeding risk in factor XI deficiency.组织因子途径抑制剂是因子 XI 缺乏症出血风险的潜在调节剂。
J Thromb Haemost. 2023 Mar;21(3):467-479. doi: 10.1016/j.jtha.2022.10.005. Epub 2022 Dec 22.
6
Obstetric and perioperative management of patients with factor XI deficiency: a retrospective observational study.因子 XI 缺乏症患者的产科和围手术期管理:一项回顾性观察研究。
Blood Adv. 2023 May 23;7(10):1967-1975. doi: 10.1182/bloodadvances.2022008648.
7
Factor XI deficiency: About 20 cases and literature review.Factor XI 缺乏症:约 20 例病例及文献复习。
Tunis Med. 2022;100(1):60-65.
8
Factor XI Inhibitors for Prevention and Treatment of Venous Thromboembolism: A Review on the Rationale and Update on Current Evidence.用于预防和治疗静脉血栓栓塞的凝血因子XI抑制剂:理论依据综述及当前证据更新
Front Cardiovasc Med. 2022 May 12;9:903029. doi: 10.3389/fcvm.2022.903029. eCollection 2022.
9
Factor XI as a target for preventing venous thromboembolism.将因子XI作为预防静脉血栓栓塞的靶点。
J Thromb Haemost. 2022 Mar;20(3):550-555. doi: 10.1111/jth.15628. Epub 2022 Jan 12.
10
The Association between Factor XI Deficiency and the Risk of Bleeding, Cardiovascular, and Venous Thromboembolic Events.因子 XI 缺乏与出血、心血管和静脉血栓栓塞事件风险的关系。
Thromb Haemost. 2022 May;122(5):808-817. doi: 10.1055/s-0041-1735971. Epub 2021 Sep 23.